Patent details

EP3083627 Title: [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PROTOZOAN PROTEASOME INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES SUCH AS LEISHMANIASIS

Basic Information

Publication number:
EP3083627
PCT Application Number:
US2014071077
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148250467
PCT Publication Number:
WO2015095477
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PROTOZOAN PROTEASOME INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES SUCH AS LEISHMANIASIS
French Title of Invention:
DÉRIVÉS DE [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE UTILISÉS COMME INHIBITEURS DU PROTÉASOME DES PROTOZOAIRES POUR LE TRAITEMENT DE MALADIES PARASITAIRES COMME LA LEISHMANIOSE
German Title of Invention:
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-DERIVATE ALS PROTOZOEN-PROTEASOME-INHIBITOREN ZUR BEHANDLUNG VON PARASITÄREN ERKRANKUNGEN WIE ETWA LEISHMANIOSE
SPC Number:

Dates

Filing date:
18/12/2014
Grant date:
05/09/2018
EP Publication Date:
26/10/2016
PCT Publication Date:
25/06/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2018
EP B1 Publication Date:
05/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2023
Expiration date:
18/12/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/08/2018
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
MOLTENI, Valentina
Address:
United States (US)

2

Name:
SUPEK, Frantisek
Address:
United States (US)

3

Name:
YEH, Vince
Address:
United States (US)

4

Name:
BIGGART, Agnes
Address:
United States (US)

5

Name:
NAGLE, Advait Suresh
Address:
United States (US)

6

Name:
MATHISON, Casey Jacob Nelson
Address:
United States (US)

7

Name:
LIANG, Fang
Address:
United States (US)

Priority

Priority Number:
201361918089 P
Priority Date:
19/12/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; A61P 33/02; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
201836
Publication date:
05/09/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/12/2022
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages